For Debate Nitric Oxide and Pancreatic P-Cell Destruction in Insulin Dependent Diabetes Mellitus: Don't Take no for an Answer

References

• Culotta E, Koshland DE. NO news is good news. Science 1992; 258: 1862–1865
   PubMed Web of Science ®Google Scholar
• Southern C, Schluster D, Green IC. Inhibition of insulin secretion by interleukin-1 (3 and tumour necrosis factor-a via an L-arginine-dependent nitric oxide generating mechanism. FEBSLett 1990; 276: 42–44
   PubMed Web of Science ®Google Scholar
• Prince RC, Gunson DE. Rising interest in nitric oxide synthase. Trends Biochem Sci 1993; 18: 35–36
   Google Scholar
• Lowenstein CJ, Snyder SH. Nitric oxide, a novel biologic messenger. Cell 1992; 70: 705–707
   PubMed Web of Science ®Google Scholar
• Cho HJ, Zie QW, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Nathan C. Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 1992; 176: 599–604
   PubMed Web of Science ®Google Scholar
• Schmidt HHHW, Waarner TD, Ishii K, Sheng H, Murad F. Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides. Science 1992; 255: 721–723
   PubMed Web of Science ®Google Scholar
• Laychock SG, Modica ME, Cavanaugh CT. L-arginine stimulates cyclic guanosine 3′, 5′-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine: nitric oxide synthase. Endocrinology 1991; 129: 3043–3052
   Google Scholar
• Jones PM, Persuad SJ, Bjaaland T, Pearson JD, Howell SL. Nitric oxide is not involved in the initiation of insulin secretion from rat islets of Langerhans. Diabetologia 1992; 35: 1020–1027
   PubMed Web of Science ®Google Scholar
• Vincent SR. Nitric oxide and arginine-evoked insulin secretion. Science 1992; 258: 1376–1376
   Google Scholar
• Green IC, Delaney CA, Cunningham JM, Karmiris V, Southern C. Interleukin-1β effects on cyclic GMP and cyclic AMP in cultured islets of Langerhans –arginine-dependence and relationship to insulin secretion. Diabetologia 1993; 36: 9–16
   Google Scholar
• Eizirik DL, Cagliero E, Björklund A, Welsh N. Interleukin-1 β induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages. FEBS Lett 1992; 308: 249–152
   PubMed Web of Science ®Google Scholar
• Hughes JH, Colca JR, Easom RA, Turk J, McDaniel ML. Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest 1990; 86: 856–863
   PubMed Web of Science ®Google Scholar
• Welsh N, Eizirik DL, Bendtzen K, Sandler S. Interleukin-1 β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 1991; 129: 3167–3173
   PubMed Web of Science ®Google Scholar
• Eizirik DL, Bjorklund A, Welsh N. Interleukin-1-induced expression of nitric oxide synthase in insulin-producing cells is preceded by c-fos induction and depends on gene transcription and protein synthesis. FEBS Lett 1993; 317: 62–66
   PubMedGoogle Scholar
• Karlsen AE, Boel E, Cuertero B, Andersen HU, Tobiasen C, Mandrup-Poulsen T, Nerup J. Detection and cloning of a novel nitric oxide synthase isoform from rat islets and RIN cells exposed to IL-1. Diabetologia 1993; 36: A76
   Google Scholar
• Bendtzen K., Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M. Cytotoxicity of human pl7 interleukin-1 for pancreatic islets of Langerhans. Science 1986; 232: 1545–1547
   PubMed Web of Science ®Google Scholar
• Nerup J, Mandrup-Poulsen T, Mølvig J. The HLA-IDDM association: implications for etiology and pathogenesis of IDDM. Diab/Metab Rev 1987; 3: 779–802
   PubMed Web of Science ®Google Scholar
• Bendtzen K. Immune hormones (cytokines); pathogenic role in autoimmune rheumatic and endocrine diseases. Autoimmunity 1989; 2: 177–189
   PubMed Web of Science ®Google Scholar
• Corbett JA, Sweetland MA, Lancaster JR, McDaniel ML. A 1-hour pulse with IL-ip induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism. FASEB J 1992; 7: 369–374
   Google Scholar
• Welsh N. A role for tyrosine kinase activation in interleukin-1 β induced nitric oxide production in the insulin producing cell line RINm-5F. Biosci Rep 1994; 14: 43–50
   Google Scholar
• Grimm S, Baeuerle PA. The inducible transcription factor NF-κ B: structure-function relationship of its protein sub-units. Biochem J 1993; 290: 197–308
   Google Scholar
• Welsh N, Bendtzen K, Sandler S. Influence of protease on inhibitory and stimulatory effects of interleukin ip on P-cell function. Diabetes 1991; 40: 290–294
   PubMed Web of Science ®Google Scholar
• Henkel T, Machleidt T, Alkalay I, Krönke M, Ben-Neriah Y, Baeuerle PA. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-KB. Nature 1993; 365: 182–185
   PubMed Web of Science ®Google Scholar
• Welsh N, Margulis B, Bendtzen K, Sandler S. Liposomal delivery of antioxidant enzymes protects against hydrogen peroxide, but not interleukin-1 β-induced inhibition of glucose metabolism in rat pancreatic islets. J Endocrinol 1994
   Google Scholar
• Hughes JH, Watson MA, Easom RA, Turk J, McDaniel ML. Interleukin-1 induces rapid and transient expression of the c-fos proto-oncogene in isolated pancreatic islets and in purified β-cells. FEBS Lett 1990; 266: 33–36
   PubMed Web of Science ®Google Scholar
• Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and it redox-activated forms. Science 1992; 258: 1896–1902
   Google Scholar
• Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Anal Biochem 1982; 126: 131–138
   PubMed Web of Science ®Google Scholar
• Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Aad Sci USA 1990; 87: 1620–1624
   PubMed Web of Science ®Google Scholar
• Rabinovitch A, Sumoski W, Rajotte RV, Warnock GL. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab 1990; 71: 152–156
   PubMed Web of Science ®Google Scholar
• Sumoski W, Baquerizo H, Rabinovitch A. Oxygen free radical scavengers protect rat islet cells from damage by cytokines. Diabetologia 1989; 32: 792–796
   PubMed Web of Science ®Google Scholar
• Ignarro LJ. Singal transduction mechanisms involving nitric oxide. Biochem Pharmacol 1991; 41: 485–490
   PubMed Web of Science ®Google Scholar
• Corbett JA, Wand JL, Hughes JH, Wolf BA, Sweetland MA, Lancaster JR, McDaniel ML. Nitric oxide and cyclic GMP formation induced by interleukin 1β in islets of Langerhans. Biochem J 1992; 287: 229–235
   PubMed Web of Science ®Google Scholar
• Sandler S, Eizirik DL, Svensson C, Strandell E, Welsh M, Welsh N. Biochemical and molecular actions of interleukin-1 on pancreatic β-cells. Autoimmunity 1991; 10: 241–253
   PubMed Web of Science ®Google Scholar
• Eizirik DL, Welsh N, Niemann A, Velloso LA, Malaisse WJ. Succinic acid monomethyl ester protects rat pancreatic islet secretory potential against interleukin-lβ (IL-1β) without affecting glutamate decarboxylase expression or nitric oxide production. FEBS Lett 1994; 337: 298–302
   Google Scholar
• Drapier J-C, Hiding H, Wietzerbin J, Kaldy P, Kühn LC. Biosynthesis of nitric oxide activated iron regulatory factor in macrophages. EMBO J 1993; 12: 3643–3649
   PubMed Web of Science ®Google Scholar
• Hibbs JB, Taintor RR, Vavrin Z, Granger DL, Drapier J-C, Amber IJ, Lancaster J, Mon-Cada S, Higgs EA. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: a molecular mechanism regulating cellular prolifration that targets intracellular iron. A bioregulatory system. Elsevier, New York 1990; 189–223
   Google Scholar
• Tao Y, Howelett A, Klein C. Nitric oxide stimulates the ADP-ribosylation of a 41-kDa cytosolic protein in Dictyos-telium discoideum. Proc Natl Acad Sci USA 1992; 89: 5902–5906
   Google Scholar
• Karanth S, Lyson K, McCann SM. Role of nitric oxide in interleukin 2-induced corticotropin releasing factor release from incubated hypothalami. Proc Natl Acad Sci USA 1993; 90: 3383–3387
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Ankarcrona M, Nicotera P, Briine B. Exogenous nitric oxide (NO) generation or IL-1 β-induced intracellular NO production stimulates inhibitory auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase in RINm5F cells. J Immunol 1993; 150: 2964–2971
   PubMed Web of Science ®Google Scholar
• Sandler S, Bendtzen K, Borg LAH, Eizirik DL, Strandell E, Welsh N. Studies on the mechanism causing inhibition of insulin secretion in rat pancreatic islets exposed to interleukin-ip indicate a perturbation in the mitochondrial function. Endocrinology 1989; 124: 1492–1501
   PubMed Web of Science ®Google Scholar
• Sjöhoim Å. Differential effects of cytokines on long-term mitogenic and secretory responses of fetal rat pancreatic β-cells. Am J Physiol 1992; 263: CI14–C120
   Google Scholar
• Hughes JH, Easom RA, Wolf BA, Turk J, McDaniel ML. Interleukin 1-induced prostaglandin E2 accumulation by isolated pancreatic islets. Diabetes 1989; 38: 1251–1257
   PubMed Web of Science ®Google Scholar
• Fehsel K, Jalowy A, Qi S, Burkart V, Hartmann B, Kolb H. Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes 1993; 42: 496–500
   PubMed Web of Science ®Google Scholar
• Corbett JA, McDaniel ML. Does nitric oxide mediate autoimmune destruction of β-cells? Possible therapeutic interventions in IDDM. Diabetes 1992; 41: 897–903
   PubMed Web of Science ®Google Scholar
• Kolb H, Kolb-Bachofen V. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol Today 1992; 13: 157–160
   PubMedGoogle Scholar
• Grankvist K, Marklund S, Taljedal I-B. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem J 1981; 199: 393–398
   PubMed Web of Science ®Google Scholar
• Malaisse WJ, Malaisse-Lagae F, Sener A, Pipeleers DG. Determinants of the selective toxicity of alloxan to the pancreatic B-cell. Proc Natl Acad Sci USA 1982; 79: 927–930
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Spinas GA, Prowse SJ. Islet cytotoxicity of interleukin 1: influence of culture conditions and islet donor characteristics. Diabetes 1987; 36: 641–647
   PubMed Web of Science ®Google Scholar
• Kröncke K-D, Rodriguez M-L, Kolb H, Kolb-Bachofen V. Cytotoxicity of activated rat macrophages against syngeneic islet cells is arginine-dependent, correlates with citrulline and nitrite concentrations and is identical to lysis by the nitric oxide donor nitroprusside. Diabetologia 1993; 36: 17–24
   PubMed Web of Science ®Google Scholar
• Corbett JA, Sweetland MA, Wang JL, Lancaster JR, McDaniel ML. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA 1993; 90: 1731–1735
   PubMed Web of Science ®Google Scholar
• Eizirik DL, Sandler S, Welsh N. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 1994; 93: 1968–1974
   PubMed Web of Science ®Google Scholar
• Welsh N, Sandler S. Interleukin-1β induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic islets. Biochem Biophys Res Commun 1992; 182: 333–340
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Bendtzen K, Nielsen JH, Bendixen G, Nerup J. Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy 1985; 40: 424–429
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Bendtzen K, Nerup J, Egeberg J, Nielsen JH. Mechanisms of pancreatic islet cell destruction. Allergy 1986; 41: 250–259
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Egeberg J, Nerup J, Bendtzen K, Nielsen JH, Dinarello CA. Ultrastructural studies of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity. Acta Path Microbiol Immunol Scand 1987; 95: 55–63
   Google Scholar
• Zumsteg U, Reimers JI, Pociot F. Differential interleukin-1 receptor antagonism on pancreatic beta and alpha cells. Studies in rodent and human islets and in normal rats. Diabetologia 1993; 36: 759–766
   PubMed Web of Science ®Google Scholar
• Kröncke K-D, Kolb-Bachofen V, Berschick B, Burkart V, Kolb H. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun 1991; 175: 752–758
   Google Scholar
• Bergmann L, Kroncke K-D, Suschek C, Kolb H, Kolb-Bachofen V. Cytotoxic action of IL-1β against pancreatic islets is mediated via nitric oxide formation and is inhibited by Ng-monomethyl-L-aginine. FEBS Lett 1992; 299: 103–106
   PubMed Web of Science ®Google Scholar
• Kleemann R, Rothe H, Kolb-Bachofen V, Xie Q-w, Nathan C, Martin S, Kolb H. Transcription and translation of inducible nitric oxide synthase in the pancreas of predia-betic BB rats. FEBS Lett 1993; 328: 9–12
   PubMed Web of Science ®Google Scholar
• Lukic ML, Stosic-Grujicic S, Ostojic N, Chan WL, Liew FY. Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice. Biochem Biophys Res Commun 1991; 178: 913–920
   PubMed Web of Science ®Google Scholar
• Kolb H, Hiesel U, Kroncke K-D, Kolb-Bachofen V. Supres-sion of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitor. Life Sci. 1991; 49: PL213–PL217
   Google Scholar
• Holstad M, Sandler S. Aminoguanidine, an inhibitor of nitric oxide formation, fails to protect against insulitis and hyperglycemia induced by multiple low dose streptozotocin injections in mice. Autoimmunity 1993; 15: 311–314
   PubMed Web of Science ®Google Scholar
• Corbett JA, Mikhael A, Shimizu J. Nitric oxide production in islets from nonobeses diabetic mice: aminoguanidine-sensitive and-resistant stages in the immunological diabetic process. Proc Natl Acad Sci USA 1993; 90: 8992–8995
   PubMed Web of Science ®Google Scholar
• Welsh M, Welsh N, Bendtzen K, Mares J, Strandell E, Öberg C, Sandler S. Comparison of mRNA contents of IL-ip and nitric oxide synthase in pancreatic islets isolated from female and male NOD mice
   Google Scholar
• Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avaium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukocyte Biol 1991; 49: 380–387
   PubMed Web of Science ®Google Scholar
• Munoz-Fernandez MA, Fernandez MA, Fresno M. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and INF-gamma through a nitric oxide-dependent mechanism. Immunol Lett 1992; 33: 35–40
   Google Scholar
• Murray HW, Teitelbaum RF. L-arginine-dependent reactive nitrogen intermediates and the antimicrobiol effect of activated human mononuclear phagocytes. J Infect Dis 1992; 165: 513–517
   PubMed Web of Science ®Google Scholar
• Padgett EL, Pruett SB. Evaluation of nitrite production by human monocyte-derived macrophages. Biochem Biophys Res Commun 1992; 186: 775–781
   PubMed Web of Science ®Google Scholar
• Schneemann M, Schoeldon G, Hofer S, Blau N, Guerrero L, Schaffner A. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis 1993; 167: 1358–1363
   PubMedGoogle Scholar
• Cetkovic-Cvrlje M, Eizirik DL. TNF-α and IFN-γ potentiate the deleterious effects of IL-1β on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 1994; 6: 399–406
   PubMed Web of Science ®Google Scholar
• Eizirik DL, Welsh N, Hellerstrom C. Predominance of stimulatory effects of interleukin-1β on isolated human pancreatic islets. J Clin Endocrinol Metab 1993; 76: 399–403
   PubMedGoogle Scholar
• Eizirik DL, Pipeleers DG, Ling Z. Major species differences between man and rodents in the susceptibility to pancreatic β-cell injury. Proc Natl Acad Sci USA 1994
   Google Scholar